A systemic study on key parameters affecting nanocomposite coatings on magnesium substrates
Source abstract
Abstract
Unlabelled Nanocomposite coatings offer multiple functions simultaneously to improve the interfacial properties of magnesium (Mg) alloys for skeletal implant applications, e.g., controlling the degradation rate of Mg substrates, improving bone cell functions, and providing drug delivery capability. However, the effective service time of nanocomposite coatings may be limited due to their early delamination from the Mg-based substrates. Therefore, the objective of this study was to address the delamination issue of nanocomposite coatings, improve the coating properties for reducing the degradation of Mg-based substrates, and thus improve their cytocompatibility with bone marrow derived mesenchymal stem cells (BMSCs). The surface conditions of the substrates, polymer component type of the nanocomposite coatings, and post-deposition processing are the key parameters that contribute to the efficacy of the nanocomposite coatings in regulating substrate degradation and bone cell responses. Specifically, the effects of metallic surface versus alkaline heat-treated hydroxide surface of the substrates on coating quality were investigated. For the nanocomposite coatings, nanophase hydroxyapatite (nHA) was dispersed in three types of biodegradable polymers, i.e., poly(lactic-co-glycolic acid) (PLGA), poly(l-lactic acid) (PLLA), or poly(caprolactone) (PCL) to determine which polymer component could provide integrated properties for slowest Mg degradation. The nanocomposite coatings with or without post-deposition processing, i.e., melting, annealing, were compared to determine which processing route improved the properties of the nanocomposite coatings most significantly. The results showed that optimizing the coating processes addressed the delamination issue. The melted then annealed nHA/PCL coating on the metallic Mg substrates showed the slowest degradation and the best coating adhesion, among all the combinations of conditions studied; and, it improved the adhesion density of BMSCs. This study elucidated the key parameters for optimizing nanocomposite coatings on Mg-based substrates for skeletal implant applications, and provided rational design guidelines for the nanocomposite coatings on Mg alloys for potential clinical translation of biodegradable Mg-based implants. Statement of significance This manuscript describes the systemic optimization of nanocomposite coatings to control the degradation and bioactivity of magnesium for skeletal implant applications. The key parameters influencing the integrity and functions of the nanocomposite coatings on magnesium were identified, guidelines for the optimization of the coatings were established, and the benefits of coating optimization were demonstrated through reduced magnesium degradation and increased bone marrow derived mesenchymal stem cell (BMSC) adhesion in vitro. The guidelines developed in this manuscript are valuable for the biometal field to improve the design of bioresorbable implants and devices, which will advance the clinical translation of magnesium-based implants.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Bone Tissue Engineering Materials · Magnesium Oxide Properties and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (88)
Show source-provided references
1. Bone-implant interface strength and osseointegration: biodegradable magnesium alloy versus standard titanium control10.1016/j.actbio.2010.08.020 ↗
2. Biodegradable magnesium-based screw clinically equivalent to titanium screw in hallux valgus surgery: short term results of the first prospective, randomized, controlled clinical pilot study10.1186/1475-925X-12-62 ↗
3. Progress and challenge for magnesium alloys as biomaterials10.1002/adem.200800035 ↗
4. Magnesium and its alloys as orthopedic biomaterials: a review10.1016/j.biomaterials.2005.10.003 ↗
5. Magnesium as a biodegradable and bioabsorbable material for medical implants10.1007/s11837-009-0129-0 ↗
6. Osteoblast response to magnesium ion-incorporated nanoporous titanium oxide surfaces10.1111/j.1600-0501.2010.01944.x ↗
7. Bone–implant interface strength and osseointegration: biodegradable magnesium alloy versus standard titanium control10.1016/j.actbio.2010.08.020 ↗
8. In vivo evaluation of biodegradable magnesium alloy bone implant in the first 6 months implantation10.1002/jbm.a.32132 ↗
9. The history of biodegradable magnesium implants: a review10.1016/j.actbio.2010.02.028 ↗
10. Degrading magnesium screws ZEK100: biomechanical testing, degradation analysis and soft-tissue biocompatibility in a rabbit model10.1088/1748-6041/8/4/045012 ↗
11. Influence of aggressive ions on the degradation behavior of biomedical magnesium alloy in physiological environment10.1016/j.actbio.2008.05.014 ↗
12. Interactions between aggressive ions and the surface of a magnesium-yttrium alloy
13. Biocorrosion behavior and cell viability of adhesive polymer coated magnesium based alloys for medical implants10.1016/j.apsusc.2012.08.051 ↗
14. A biodegradable polymer-based coating to control the performance of magnesium alloy orthopaedic implants10.1016/j.biomaterials.2009.11.111 ↗
15. Properties of osteoconductive biomaterials: calcium phosphates10.1097/00003086-200202000-00009 ↗
16. Osteoconductive coatings for total joint arthroplasty10.1097/00003086-200202000-00007 ↗
17. Hydroxyapatite coating of titanium implants using hydroprocessing and evaluation of their osteoconductivity10.1155/2012/730693 ↗
18. Enhanced functions of osteoblasts on nanophase ceramics10.1016/S0142-9612(00)00075-2 ↗
19. Electrodeposition of hydroxyapatite coating on Mg-4.0Zn-1.0Ca-0.6Zr alloy and in vitro evaluation of degradation, hemolysis, and cytotoxicity10.1002/jbm.a.34042 ↗
20. Influence of residual stress on bonding strength of the plasma-sprayed hydroxyapatite coating after the vacuum heat treatment10.1016/j.surfcoat.2007.01.027 ↗
21. The effect of adhesive strength of hydroxyapatite coating on the stability of hydroxyapatite-coated prostheses in vivo at the early stage of implantation10.5114/aoms.2012.28545 ↗
22. Nanostructured hydroxyapatite/poly(lactic-co-glycolic acid) composite coating for controlling magnesium degradation in simulated body fluid10.1088/0957-4484/24/37/375103 ↗
23. Biodegradable poly(lactide-co-glycolide) coatings on magnesium alloys for orthopedic applications10.1007/s10856-012-4773-5 ↗
24. In vitro degradation and cell attachment of a PLGA coated biodegradable Mg-6Zn based alloy10.1007/s10853-010-4688-9 ↗
25. In vitro degradation of biodegradable polymer-coated magnesium under cell culture condition10.1016/j.apsusc.2012.03.036 ↗
26. Characteristics and cytocompatibility of biodegradable polymer film on magnesium by spin coating10.1016/j.colsurfb.2011.12.009 ↗
27. Hybrid coating on a magnesium alloy for minimizing the localized degradation for load-bearing biodegradable mini-implant applications10.1016/j.matchemphys.2013.07.028 ↗
28. Biocorrosion and osteoconductivity of PCL/nHAp composite porous film-based coating of magnesium alloy10.1016/j.solidstatesciences.2012.11.017 ↗
29. Reduction of corrosion behavior of magnesium alloy by PCL surface treatment
30. Hydroxyapatite/poly (ɛ-caprolactone) double coating on magnesium for enhanced corrosion resistance and coating flexibility
31. The return of a forgotten polymer—polycaprolactone in the 21st century10.1016/j.progpolymsci.2010.04.002 ↗
32. Effect of isothermal annealing on the hydrolytic degradation rate of poly(lactide-co-glycolide) (PLGA)10.1016/j.biomaterials.2004.08.031 ↗
33. Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres10.1016/S0168-3659(03)00367-5 ↗
34. Properties and morphologies of poly(l-lactide). 1. Annealing condition effects on properties and morphologies of poly(l-lactide)10.1016/0032-3861(95)93647-5 ↗
35. Severe cartilage damage by broken poly-l-lactic acid (PLLA) interference screw after ACL reconstruction10.1007/s00167-004-0545-1 ↗
36. Clinical degradation and biocompatibility of different bioabsorbable interference screws: a report of six cases10.1016/S0749-8063(97)90162-6 ↗
37. Polymer-hydroxyapatite composite versus polymer interference screws in anterior cruciate ligament reconstruction in a large animal model10.1007/s00167-008-0528-8 ↗
38. Interaction of human chondrocytes and NIH/3T3 fibroblasts on chloric acid-treated biodegradable polymer surfaces10.1163/156856202317414375 ↗
39. Osteogenesis and angiogenesis: the potential for engineering bone10.22203/eCM.v015a08 ↗
40. Degradation of and tissue reaction to biodegradable poly(l-lactide) for use as internal fixation of fractures: a study in rats10.1016/0142-9612(91)90128-W ↗
41. Long-term tissue response to bioabsorbable poly-l-lactide and metallic screws: an experimental study10.1016/j.bone.2006.04.009 ↗
42. Long-term in vivo degradation of poly-l-lactide (PLLA) in bone10.1177/0885328206065125 ↗
43. Long-term absorption of poly-l-lactic acid interference screws10.1016/j.arthro.2006.04.096 ↗
44. Mechanical properties of dispersed ceramic nanoparticles in polymer composites for orthopedic applications
45. Enhanced biological and mechanical properties of well-dispersed nanophase ceramics in polymer composites: from 2D to 3D printed structures10.1016/j.msec.2010.07.013 ↗
46. Evaluating and modeling the mechanical properties of the prepared PLGA/nano-BCP composite scaffolds for bone tissue engineering10.1016/S1005-0302(12)60004-8 ↗
47. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering10.1016/j.biomaterials.2003.12.005 ↗
48. Nanophase hydroxyapatite and poly(lactide-co-glycolide) composites promote human mesenchymal stem cell adhesion and osteogenic differentiation in vitro10.1007/s10856-012-4709-0 ↗
49. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
50. Bone marrow stromal cell adhesion and morphology on micro- and sub-micropatterned titanium10.1166/jbn.2014.1760 ↗
51. Barrier properties of polylactic acid in cellulose based packages using montmorillonite as filler10.3390/polym6092386 ↗
52. In vitro cell response to differences in poly-l-lactide crystallinity10.1002/jbm.1996.820310102 ↗
53. Adhesion of human peripheral blood lymphocytes is dependent on surface wettability and protein preadsorption10.1016/0142-9612(94)90220-8 ↗
54. Cell adhesion on gaseous plasma modified poly-(l-lactide) surface under shear stress field10.1016/S0142-9612(03)00251-5 ↗
55. Nanostructured hydroxyapatite/poly(lactic-co-glycolic acid) composite coating for controlling magnesium degradation in simulated body fluid10.1088/0957-4484/24/37/375103 ↗
56. Lacombe · 2005
57. PoLyInfo, Materials Information Station, 2015.
58. Van Vooren · 2012
59. Seawater ageing of flax/poly (lactic acid) biocomposites10.1016/j.polymdegradstab.2009.03.025 ↗
60. Two-dimensional infrared correlation spectroscopy as a probe of sequential events in the diffusion process of water in poly(ε-caprolactone)10.1063/1.1610441 ↗
61. Miscibility, thermal characterization and crystallization of poly (l-lactide) and poly (tetramethylene adipate-co-terephthalate) blend membranes10.1016/j.polymer.2005.10.100 ↗
62. Effect of hydration on physicochemical properties of end-capped PLGA10.1155/2014/834942 ↗
63. Simultaneous biaxial drawing of poly (epsilon-caprolactone) films10.1016/S0032-3861(99)00760-0 ↗
64. Auras · 2011
65. Electrodeposition of hydroxyapatite coating on Mg-4.0 Zn-1.0 Ca-0.6 Zr alloy and in vitro evaluation of degradation, hemolysis, and cytotoxicity10.1002/jbm.a.34042 ↗
66. Crystallization kinetics of poly(l-lactide)/carbonated hydroxyapatite nanocomposite microspheres10.1002/app.30527 ↗
67. Studying the degradation of poly (l-lactide) in presence of magnesium hydroxide
68. Structure and properties of polypropylene composites filled with magnesium hydroxide10.1002/app.24938 ↗
69. Effects of magnesium hydroxide and its surface modification on crystallization and rheological behaviors of polypropylene10.1002/pc.20638 ↗
70. Cracking in polylactide spherulites10.1002/polb.20616 ↗
71. Cathodic delamination of seawater-immersed anticorrosive coatings: mapping of parameters affecting the rate10.1016/j.porgcoat.2010.03.012 ↗
72. Competition between crystallization and dewetting fronts in thin polymer films10.1039/B806074F ↗
73. Crystallization-induced fluid flow in polymer melts undergoing solidification10.1021/ma0628174 ↗
74. Influences of tensile load on in vitro degradation of an electrospun poly(l-lactide-co-glycolide) scaffold10.1016/j.actbio.2010.02.023 ↗
75. Effect of coating stress on adherence and on corrosion prevention10.1016/S0300-9440(01)00243-0 ↗
76. The origin of residual internal stress in solvent-cast thermoplastic coatings10.1002/app.1979.070230319 ↗
77. Hygroscopic stress and failure of coating/metal systems
78. Schneller · 2010
79. Weldon · 2009
80. Effect of film formation method and annealing on morphology and crystal structure of poly (l-lactic acid) films10.1115/1.4025909 ↗
81. Melt structure and its transformation by sequential crystallization of the two blocks within poly(l-lactide)-block-poly(epsilon-caprolactone) double crystalline diblock copolymers10.1002/macp.200600085 ↗
82. Influence of electrospinning and dip-coating techniques on the degradation and cytocompatibility of Mg-based alloy10.1016/j.colsurfa.2012.12.009 ↗
83. Recent progress in corrosion protection of magnesium alloys by organic coatings10.1016/j.porgcoat.2011.10.011 ↗
84. Polymer–bioceramic composite coatings on magnesium for biomaterial applications10.1016/j.surfcoat.2013.10.029 ↗
85. Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour10.1007/s10856-006-0032-y ↗
86. Effects of magnesium-substituted nanohydroxyapatite coating on implant osseointegration10.1111/j.1600-0501.2011.02362.x ↗
87. Magnesium ions facilitate integrin alpha 2- and alpha 3-mediated proliferation and enhance alkaline phosphatase expression and activity in hBMSCs
88. Investigation of magnesium-zinc-calcium alloys and bone marrow derived mesenchymal stem cell response in direct culture10.1016/j.actbio.2014.10.018 ↗